Schroder Investment Management Group Pharvaris N.V. Transaction History
Schroder Investment Management Group
- $122 Billion
- Q3 2025
A detailed history of Schroder Investment Management Group transactions in Pharvaris N.V. stock. As of the latest transaction made, Schroder Investment Management Group holds 12,073 shares of PHVS stock, worth $292,890. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,073Holding current value
$292,890% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PHVS
# of Institutions
73Shares Held
48.5MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY8.03MShares$195 Million7.09% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.41MShares$107 Million85.48% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$104 Million79.45% of portfolio
-
Viking Global Investors LP3.65MShares$88.6 Million0.2% of portfolio
-
Eqt Fund Management S.A R.L.3.42MShares$83.1 Million4.59% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $819M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...